We are looking for products for CNS disorders. In particular new modern epilepsy drugs, new alzheimer drugs, anti- psychotics, anti-depressants, parkinson's disease, modern migraine drugs (NOT triptanes).
In-licensing opportunities with exclusive rights to market and sell the product in Finland